Kenneth C. Frazier, chairman and chief executive officer of Merck, sat down with Tony Coles, M.D., chairman and chief executive officer of Yumanity Therapeutics and chairman of Cerevel Therapeutics, ...

Kenneth C. Frazier is exactly the type of exceptional ... As a CEO, he has directed Merck to increase its investment in bold, lifesaving treatments. As a leader, he has advised—and stood up ...

Merck & Co’s CEO Kenneth Frazier has said the pharma industry must take on the challenge of its poor public perception. In an interview with Yahoo Finance, Frazier defended the industry’s ...

Kenneth Frazier was talking ... said Frazier in the interview. Merck has four drugs currently under regulatory review: a new house dust mite treatment MK-8237, c diff antibacterial Zinplava ...

and Kenneth C. Frazier Family Foundation ... Kenneth Frazier is the former CEO of Merck and serves as the chairman of Health ...

Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...

Merck said Thursday that it would lower the price of some of its medications including its hepatitis C drug Zepatier by 60 ... Amid Merck CEO Ken Frazier's withdrawal from Trump's manufacturing ...

Frazier took a risk by becoming the first of Trump’s advisers to speak out and step down, enabling others to follow suit. His success at Merck only bolsters his credibility: Since he took over ...